Ed Amer, a partner in Goodwin's Private Equity Group, represents private equity and venture capital firms, operating companies and investors in a broad range of transactions, including leveraged buyouts, carve-outs, exits, growth equity financings and general corporate representation, with a particular focus on the healthcare and life science industries. Prior to pursuing a career in law, Mr. Amer worked as a lighting technician in the motion picture industry.

Experience

ERFAHRUNG

工作经历

Mr. Amer’s recent representations include:

M&A:

  • Teva Pharmaceuticals in the sale of its Plan B One Stop product and related assets to Foundation Consumer Healthcare.
  • Agilux Laboratories, an Ampersand Capital Partners portfolio company, in its sale to Charles River Laboratories.
  • TA Associates in its acquisition of National Intergovernmental Purchasing Alliance, a group purchasing organization serving public agencies and educational institutions.
  • Confluent Medical in its acquisition of Interface Catheter Solutions, a contract manufacturer of balloon catheter systems.
  • MPI research, an early stage drug development clinical research organization, in its sale to Avista Capital Partners.
  • DigiCert, a leading digital certificate provider, in its majority acquisition by Thoma Bravo.
  • ViraCor-IBT Laboratories, a premier specialty diagnostics laboratory, in its acquisition by Eurofins Scientific.*

Carve-Outs:

  • Brammer Bio, a cell and gene therapy biologics contract development and manufacturing organization, in its acquisition of a biologics manufacturing facility from Biogen.
  • Ampersand Capital Partners and 1315 Capital in their acquisition of Genoptix, an oncology diagnostics company, from Novartis.
  • Avista Pharma in its acquisition of the GMP contract manufacturing, development and animal health services business of Scynexis.

Growth Equity:

  • Ampersand Capital Partners in its acquisition of a majority stake in Corpus Medical, a contract developer and manufacturer of interventional medical devices.
  • Primus Capital Partners in its investment in EnableComp, a healthcare technology company providing workers compensation reimbursement services.
  • Florida Biologix in its merger with Brammer Biopharmaceuticals, forming Brammer Bio, and simultaneous growth equity investment.
  • Ampersand Capital Partners in its minority investment in CutisPharma, an industry leader in prescription compounding pharmaceuticals.*

*Denotes experience prior to joining Goodwin. 

Professional Experience

Prior to joining Goodwin in 2015, Mr. Amer was a partner at Locke Lord in Boston.

Recognition

In law school, Mr. Amer served on the Boston College Law Review and was a member of the Order of the Coif.

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 2004
Boston College Law School

(magna cum laude)

B.A., 1992
Bowdoin College

Admissions

Bar

Massachusetts
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师